GlassScriptPhysician profile
Frances Charles Schmidt
NPI 1710602081
$1,300.40
in general payments reported to CMS, 2019-2025
16 companies · $570 in 2025
The $570 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.45 · 2023: $276 · 2024: $419 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.97 |
| Education | $189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $229.47 | 2024-2025 | Tremfya |
| Leo Pharma INC. | $179.65 | 2023-2025 | Adbry, Anzupgo |
| Incyte Corporation | $168.58 | 2023-2024 | Opzelura |
| Abbvie INC. | $166.47 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $93.37 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $92.27 | 2023-2024 | Sotyktu |
| Genzyme Corporation | $70.16 | 2022-2025 | |
| Almirall LLC | $62.05 | 2025 | Klisyri, Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.65 | 2023-2024 | Arazlo |
| Ucb, INC. | $53.17 | 2025 | Bimzelx |
| Botanix Sb INC | $38.76 | 2025 | Sofdra |
| Regeneron Healthcare Solutions, INC. | $29.98 | 2024 | Libtayo |
| Medimetriks Pharmaceuticals, INC. | $18.43 | 2025 | Clindacin Etz |
| Journey Medical Corporation | $16.65 | 2022 | |
| Fresenius Kabi USA, LLC | $14.13 | 2024 | Idacio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $13.61 | 2023 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frances Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.